Research Impact Awards Results
2024
| Name | Supervisor | Amount | Title of Article |
|---|---|---|---|
| Amelia Chen | Joanne Lemieux | $1,000 | SARS-CoV‑2 Mpro protease variants of concern display altered viral substrate and cell host target Galectin-8 processing but retain sensitivity toward antivirals |
| Amirhossein Rahmati | Shokrollah Elahi | $1,000 | Galectin-9 promotes natural killer cells activity via interaction with CD44 |
| TOTAL | $2,000 |
Research Impact Awards 2023
| Name | Supervisor | Amount | Title of Article |
|---|---|---|---|
| Ivan Domingo | Amit Bhavsar | $1,000 | Cisplatin toxicity is mediated by direct binding to Toll-like receptor 4 through a mechanism that is distinct from metal allergens |
| Justine Kniert | Maya Shmulevitz | $1,000 | Reovirus uses temporospatial compartmentalization to orchestrate core versus outercapsid assembly |
| Shima Shabaz | Shokrollah Elahi | $1,000 | Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals |
| Reegan Willms | Edan Foley | $1,000 | A cell atlas of microbe-responsive processes in the zebrafish intestine |
| TOTAL | $4,000 |
Research Impact Awards 2022
| Name | Supervisor | Amount | Title of Article |
|---|---|---|---|
| Lee Campbell | Katharine Magor | $1,000 | Tissue specific transcriptome changes upon influenza A virus replication in the duck |
| Ghazal Babolmorad | Amit Bhavsar | $1,000 | Toll-like receptor 4 is activated by platinum and contributes to cisplatin-inducedototoxicity |
| Daniel Limonta | Tom Hobman | $1,000 | Nodosome inhibition as a novel broad-spectrum antiviral strategy against arboviruses, enteroviruses, and SARS-CoV-2 |
| Shima Shabaz | Shokrollah Elahi | $1,000 | Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2 |
| Meng Zhao | Michael Woodside | $1,000 | Mechanical strength of RNA knot in Zika virus protects against cellular defenses |
| TOTAL | $5,000 |
Research Impact Awards 2021
| Name | Supervisor | Amount | Title of Article |
|---|---|---|---|
| Calvin Gordon | Matthias Götte | $1,000 | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency |
| Cameron Griffiths | David Marchant | $1,000 | IGF1R is an entry receptor for respiratory syncytial virus |
| Shima Shabaz | Shokrollah Elahi | $1,000 | Galectin-9 and VISTA expression define terminally exhausted T cells in HIV-1 infection |
| Brittany Umer | David Evans | $1,000 | Deciphering the immunomodulatory capacity of oncolytic vaccinia virus to enhance the immune response to breast cancer |
| TOTAL | $4,000 |